The therapy involves taking stem cells out of a patient's bone marrow and editing a gene in the cells in a laboratory and ...

We recently published a list of 9 Stocks Jim Cramer Talked About. In this article, we are going to take a look at where ...

A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease. Casgevy, also ...

NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...

Sublingual Allergy Immunotherapy Market The rising of allergic diseases, such as allergic rhinitis and asthma, is a factor driving the grow ...

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...

In a challenging year for biotech firms, Caribou Biosciences Inc. has seen its stock tumble to a 52-week low, touching down at $1.32. According to InvestingPro data, the stock's RSI indicates oversold ...

The global liquid biopsy tube market exhibits promising growth prospects, driven by advancements in cancer diagnostics and the increasing prevalence of ...

January 31, 2025 expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for severe sickle cell disease . Scientists comment on final draft guidance fro ...